EC Number |
Protein Variants |
Reference |
---|
3.2.1.123 | E351S |
the endo-glycoceramidase II nucleophile mutant E351S has glycosynthase activity |
714723 |
3.2.1.123 | E351W |
mutant glycosidase with no glycosynthase activity |
695545 |
3.2.1.123 | E351Y |
mutant glycosidase with no glycosynthase activity |
695545 |
3.2.1.123 | K61A |
no hydrolysis of beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide and beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide |
-, 751102 |
3.2.1.123 | N213A |
no hydrolysis of beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide and beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide |
-, 751102 |
3.2.1.123 | N265A |
no hydrolysis of beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide. Hydrolysis of beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide is 2.1% compared to wild-type enzyme |
751102 |
3.2.1.123 | Q298A |
no hydrolysis of beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide and beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide |
-, 751102 |
3.2.1.123 | S63G |
the mutant enzyme shows a broader substrate spectrum and significantly increased activity toward bulky substrates |
751102 |
3.2.1.123 | W365A |
no hydrolysis of beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide and beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide |
751102 |
3.2.1.123 | Y302A |
no hydrolysis of beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide and beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide |
751102 |